Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant
Clinical studies could begin as early as August, subject to regulatory approvals, Pfizer says.
—————
TRANSCOM ISP – Free Sigma HSE Email
Level 6 Domain Names are FREE – Register Now.